| STUDY | ACCR. GOAL |
R E G |
O P E N |
ARM | TOTAL REGS. |
REGS. LAST 12 Month |
REGS. LAST 6 Month |
REGS. LAST 3 Month |
REGS. LAST 30 DAYS |
REGS. LAST 7 DAYS |
DATE OF FIRST REG. |
# of ACT. INSTs |
# of CURR IRBs |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| S1703-Met Breast, STM-monitoring v Usual Care | 739 | 1 | Y | 0 Screening | 663 | 100 | 43 | 16 | 6 | 0 | 09/17/2018 | 238 | 92 |
| 663 | 100 | 43 | 16 | 6 | 0 | ||||||||
| 2 | Y | 1 Control (Usual Care) | 220 | 28 | 13 | 6 | 0 | 0 | 09/17/2018 | 238 | 92 | ||
| 2 Intervention (STMDDM) | 226 | 33 | 17 | 9 | 3 | 0 | 09/17/2018 | 238 | 92 | ||||
| 446 | 61 | 30 | 15 | 3 | 0 | ||||||||
| S2417CD-Colrec Surv, Follow-up w/ CTAC site | 654 | 1 | Y | 1 CTAC Intervention | 19 | 19 | 19 | 14 | 7 | 1 | 10/15/2025 | 155 | 40 |
| 2 CTAC Control | 10 | 10 | 10 | 7 | 6 | 0 | 10/15/2025 | 155 | 40 | ||||
| 29 | 29 | 29 | 21 | 13 | 1 | ||||||||
| A231602C-Blood Cancer, Assess Financial Difficulty | 1 | T | 4 | 0 | 0 | 0 | 0 | 0 | 06/04/2020 | ||||
| 4 | 0 | 0 | 0 | 0 | 0 | ||||||||
| ACCL16N1-Guideline Consistent Treatment AYA ALL | 1 | T | 54 | 0 | 0 | 0 | 0 | 0 | 10/24/2018 | ||||
| 54 | 0 | 0 | 0 | 0 | 0 | ||||||||